for medical school, where he was selected for the Alpha Omega Alpha medical honor society. After graduating from Duke University School of Medicine, he completed a residency in internal medicine at the University of California, San Francisco, then returned to Duke for a cardiology fellowship. Dr. Califf is board certified in internal medicine and cardiology, and was named a Master of the American College of Cardiology in 2006. An international leader in the fields of cardiovascular medicine, health care outcomes, quality of care, and medical economics, he has authored or coauthored more than 1,000 peer-reviewed articles and is among the most frequently cited authors in medicine. He is also a contributing editor for, an online information resource for health care professionals working in the field of cardiovascular medicine. As founder and a decade-long director of the DCRI, Dr. Califf led many landmark clinical trials and health services research projects, and remains actively involved in designing, leading, and conducting multinational clinical trials. Under his guidance, DCRI grew into an organization with more than 1,000 employees and an annual budget of more than $100 million; its umbrella organization, the DTMI, now has an annual budget of more than $300 million. Supported in part by a Clinical and Translational Science Award (CTSA) from the National Institutes of Health, the DTMI works with government agencies, academic partners, research foundations, and the medical products industry to conduct innovative research spanning multiple therapeutic arenas and scientific disciplines. Dr. Califf serves as co-chair of the first Principal Investigators Steering Committee of the CTSA. He has served on the Food and Drug Administration’s (FDA’s) Cardiorenal Advisory Panel, and on the Institute of Medicine’s Committee on Identifying and Preventing Medication Errors, and Committee on Nutritional Biomarkers. In 2008, he was part of the subcommittee of the FDA’s Science Board that recommended sweeping reform of the agency’s science base. He was also a member of the IOM committees that recommended Medicare coverage of clinical trials and the removal of ephedra from the market. Dr. Califf is currently a member of the Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation and a member of the National Advisory Council on Aging. Reflecting his interests in health care quality, Dr. Califf was the founding director of the coordinating center of the Centers for Education & Research on Therapeutics, a public-private partnership that seeks to improve the use of medical products through research and education. He is currently co-chair of the Clinical Trials Transformation Initiative, a public-private partnership focused on improving the clinical trials sys-

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement